Variable* | Survivor (N = 1867) | Nonsurvivor (N = 75) | P† |
---|---|---|---|

Age, mo | 10.0 (0.7–48.0) | 1.0 (0.0–24.0) | <.001 |

Male gender, n (%) | 1041 (55.8%) | 41 (54.7%) | .946 |

Prematurity, n (%) | 77 (4.1%) | 14 (18.7%) | <.001 |

PRISM score | 4 (0–6) | 14 (4–26.5) | <.001 |

Admitted to ICU, n (%) | 1032 (55.3%) | 70 (93.3%) | <.001 |

CPOE, n (%) | 512 (27.4%) | 36 (48.0%) | <.001 |

Airway/respiratory, n (%) | 788 (42.2%) | 40 (53.3%) | .073 |

Infectious disease, n (%) | 661 (35.4%) | 16 (21.3%) | .017 |

CNS/neuromuscular, n (%) | 365 (19.6%) | 12 (16.0%) | .540 |

Surgical referral, n (%) | 322 (17.2%) | 24 (32.0%) | .002 |

Gastrointestinal, n (%) | 258 (13.8%) | 7 (9.3%) | .348 |

GCS score ≤8, n/N (%) | 208/1853 (11.2%) | 37/74 (50.0%) | <.001 |

Metabolic/renal/ingestion, n (%) | 220 (11.8%) | 1 (1.3%) | .009 |

Cardiovascular, n (%) | 141 (7.6%) | 18 (24.0%) | <.001 |

Shock, n (%) | 138 (7.4%) | 18 (24.0%) | <.001 |

Congenital/genetic, n (%) | 84 (4.5%) | 9 (12.0%) | .007 |

Hematologic/oncologic, n (%) | 55 (2.9%) | 2 (2.7%) | 1.000 |

Other diagnosis, n (%) | 50 (2.7%) | 2 (2.7%) | 1.000 |

ECMO referral, n (%) | 27 (1.4%) | 7 (9.3%) | <.001 |

↵* Clinical categories are not mutually exclusive (eg, meningococcemia = infectious disease and shock). Continuous data are presented as median (interquartile range). Categorical data are presented as percentages of survivors and nonsurvivors.

↵†

*P*values reflect comparisons between survivors and nonsurvivors, as determined by Mann-Whitney rank sum test for continuous data and χ^{2}or Fisher's exact tests for categorical data.